Nektar Therapeutics (NKTR) 17.75 $NKTR Can Cerner (CERN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nektar Therapeutics (NKTR) 17.75 $NKTR

Can Cerner (CERN) Spring a Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:45PM CDT
Cerner Corporation (CERN) is expected to report second-quarter 2016 results on Aug 2.
ANIP: 60.01 (-0.59), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46), CERN: 62.57 (+0.18)

Cardinal Health (CAH) Q4 Earnings: Disappointment in Store?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:01PM CDT
Cardinal Health Inc. (CAH) is set to report fourth-quarter fiscal 2016 earnings results on Aug 2.
ANIP: 60.01 (-0.59), CAH: 83.29 (-0.31), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46)

UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:15AM CDT
UCB (UCBJF) reported results for the first half of 2016.
BIIB: 305.29 (+15.36), AMGN: 174.32 (+2.29), NKTR: 17.75 (+0.46)

Agenus (AGEN) Posts Narrower than Expected Loss in Q2
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:47AM CDT
Agenus (AGEN) reported first-quarter 2016 loss of 24 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents.
AGEN: 5.65 (+0.10), ANIP: 60.01 (-0.59), MRK: 58.87 (+0.21), NKTR: 17.75 (+0.46)

ARIAD's (ARIA) Stock Up on Q2 Earnings & Revenue Beat
Arpita Dutt - Zacks Investment Research - Fri Jul 29, 8:23AM CDT
ARIAD (ARIA) swung to earnings in the second quarter while Iclusig sales continued to grow.
ZTS: 50.58 (+0.11), INCY: 90.66 (+0.45), ARIA: 9.69 (+0.18), NKTR: 17.75 (+0.46)

AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:16AM CDT
AstraZeneca (AZN) reported second-quarter 2016 core earnings of 83 cents per American Depositary Share, beating the Zacks Consensus Estimate of 42 cents.
INVA: 12.94 (+0.07), ANIP: 60.01 (-0.59), AZN: 33.94 (-0.20), NKTR: 17.75 (+0.46)

Becton, Dickinson (BDX) Q3 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:01AM CDT
Becton, Dickinson and Company (BDX) is set to report third-quarter fiscal 2016 earnings results on Aug 4.
BDX: 177.22 (+1.22), ANIP: 60.01 (-0.59), GLYC: 8.62 (+0.27), NKTR: 17.75 (+0.46)

Nektar Therapeutics (NKTR) Worth a Look: Stock Gains 6.1%
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:45AM CDT
Nektar Therapeutics (NKTR) was a big mover last session, as the company saw its shares rise over 6% on the day.
AKAO: 3.93 (unch), NKTR: 17.75 (+0.46)

Can Ecolab (ECL) Spring an Earnings Surprise in Q2?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:10PM CDT
Ecolab Inc. (ECL) is slated to announce second-quarter 2016 earnings results on Aug 2, 2016.
ZTS: 50.58 (+0.11), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46), ECL: 118.60 (+0.22)

Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:33AM CDT
Alexion's (ALXN) second-quarter 2016 earnings of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents.
INVA: 12.94 (+0.07), ANIP: 60.01 (-0.59), ALXN: 133.28 (+4.68), NKTR: 17.75 (+0.46)

Weight Watchers (WTW) Q2 Earnings: A Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:57AM CDT
Weight management service provider Weight Watchers International Inc. is scheduled to release second-quarter 2016 results on Aug 4.
ZTS: 50.58 (+0.11), CYTR: 0.60 (-0.05), WTW: 11.53 (-0.40), NKTR: 17.75 (+0.46)

Nektar to Announce Financial Results for the Second Quarter 2016 on Wednesday, August 3, 2016, After Close of U.S.-Based Financial Markets
PR Newswire - Wed Jul 27, 4:15PM CDT
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2016, on Wednesday, August 3, 2016, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).
NKTR: 17.75 (+0.46)

Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:07AM CDT
Gilead Sciences' (GILD) second-quarter 2016 earnings beat the Zacks Consensus Estimate by a penny while revenues missed estimates; product sales outlook is lowered.
INVA: 12.94 (+0.07), FCSC: 1.03 (-0.06), GILD: 80.91 (+1.44), NKTR: 17.75 (+0.46)

HCA Holdings (HCA) Q2 Earnings: Uncertainty in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 5:24PM CDT
HCA Holdings Inc. (HCA) is set to report second-quarter 2016 results on Jul 28.
ZTS: 50.58 (+0.11), HCA: 76.06 (-1.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Merck KGaA's Multiple Sclerosis Drug under Review in EU
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 8:23AM CDT
Merck MGaA (MKGAF) announced that the EMA has accepted to review its MAA for cladribine tablets for the treatment of relapsing-remitting MS.
INVA: 12.94 (+0.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Evoke (EVOK) Stock Down on Poor Phase III EVK-001 Data
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 8:08AM CDT
Evoke (EVOK) announced unfavorable top-line data from a phase III study on EVK-001 for the treatment of female patients with symptomatic diabetic gastroparesis.
EVOK: 2.72 (+0.10), INVA: 12.94 (+0.07), CYTR: 0.60 (-0.05), NKTR: 17.75 (+0.46)

Pre-market Equity Watch on Biotechnology -- Infinity Pharma, Nektar Therapeutics, Aralez Pharma, and BIND Therapeutics
PR Newswire - Thu Jun 23, 7:20AM CDT
On Wednesday, June 22, 2016, the NASDAQ Composite ended the trading session at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% lower to finish at 17,780.83; and the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Nektar Therapeutics (NASDAQ: NKTR), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), and BIND Therapeutics Inc. (NASDAQ: BIND). Learn more about these stocks by accessing their free trade alerts at:
BIND: 0.78 (-0.09), ARLZ: 3.95 (+0.45), INFI: 1.66 (-0.02), NKTR: 17.75 (+0.46)

Preclinical Data Presented at ASCO 2016 Annual Meeting Demonstrate that Single-Agent NKTR-214 Produces a Large Increase in Tumor-Infiltrating Lymphocytes to Provide Durable Anti-Tumor Activity
PR Newswire - Mon Jun 06, 1:00PM CDT
Nektar Therapeutics (NASDAQ: NKTR) today announced new preclinical data for NKTR-214, an immuno-stimulatory CD-122 biased cytokine currently being evaluated in cancer patients with solid tumors in a Phase 1/2 clinical trial being conducted at MD Anderson Cancer Center and Yale Cancer Center. The new preclinical data presented demonstrate that treatment with single-agent NKTR-214 mobilizes tumor-killing T cells into colon cancer tumors. In addition, mouse pharmacodynamics data demonstrated that a single dose of NKTR-214 can increase and sustain STAT5 phosphorylation (a marker of IL-2 pathway activation) through one week post-dose. These data were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 3-7, 2016.
NKTR: 17.75 (+0.46)

Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2016 Global Healthcare Conference in New York City
PR Newswire - Thu Jun 02, 5:30PM CDT
Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming Jefferies 2016 Global Healthcare Conference in New York City on Wednesday, June 8, 2016 at 11:30 a.m. Eastern time.
NKTR: 17.75 (+0.46)

Nektar Therapeutics Announces Executive Management Promotions
PR Newswire - Thu Jun 02, 3:30PM CDT
Nektar Therapeutics (NASDAQ: NKTR) announced today that John Nicholson has been named Senior Vice President & Chief Operating Officer and Gil M. Labrucherie has been named Senior Vice President & Chief Financial Officer of Nektar. Mr. Nicholson has served as the Chief Financial Officer of Nektar since 2007. Mr. Labrucherie has served as Senior Vice President, General Counsel and Secretary of Nektar since 2007.
NKTR: 17.75 (+0.46)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 0

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 51

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 416

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Univers Partners to Propel Physical AI Across Industries

Updated Category News Views 40

Univers Sets Sights on Global Physical AI Expansion Now here's a tune we've been humming for a while—AI is coming to take over the mundane, and Univers seems to think it's got the right band together to make that a full-blown concert in the built environment. Announced right in the heart of Antalya, Türkiye, at the esteemed COP31, we're seeing Univers grab hands with...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 51

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 372

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 0

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 25

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 27

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Labcon and Polycarbin Forge Sustainable Partnership for Labs

Updated Category News Views 93

Labcon Teams Up with Polycarbin for Sustainable Solutions Labcon North America, known for its commitment to Earth Friendly® laboratory disposables, is partnering with Polycarbin, a leader in sustainable laboratory solutions. This strategic alliance aims to promote a circular economy within the life sciences and pharmaceutical industries. Joining Forces for Circular...

Continue Reading
Toobit Innovates with New Card Payment for Cryptocurrency Purchases

Updated Category News Views 141

Toobit Introduces Hassle-free Cryptocurrency Purchases Toobit, a leading name in the cryptocurrency market, is breaking new ground by launching a feature that allows users to buy digital currencies using credit and debit cards. This innovative approach is set to simplify the purchasing process, enabling customers to engage in the world of cryptocurrencies with ease and...

Continue Reading
Exploring the UAE's Growing $40.8 Billion Wellness Landscape

Updated Category News Views 222

The UAE's Flourishing Wellness Economy In collaboration with key stakeholders, recent findings indicate that the wellness economy in the UAE has experienced impressive growth of 14.3% from 2019 to 2024. This demonstrates its status as the fastest-growing wellness market in the region. Valuation of the Wellness Sector The value of the wellness industry in the UAE has...

Continue Reading
Waylens Partners with Greater Than for Enhanced Fleet Safety

Updated Category News Views 165

Waylens and Greater Than Join Forces for Fleet Safety In an exciting development for the fleet management industry, Waylens, recognized for its cutting-edge AI video telematics technology, is partnering with Greater Than, a leading provider of risk intelligence focused on road safety and climate impacts. This collaboration aims to enhance fleet safety by integrating video...

Continue Reading
Heavy Options Trading Indicates Optimism for NuScale Power

Updated Category News Views 185

NuScale Power Sees Significant Options Activity Investors are increasingly showing a positive outlook towards NuScale Power (NYSE: SMR), an engagement worth noting in the market landscape. Recent tracking of public options records has revealed notable movements among deep-pocketed investors today. Understanding the Options Landscape Today, the options scanner brought to...

Continue Reading